טוען...
Chemotherapy and Chemoprevention by Thiazolidinediones
Thiazolidinediones (TZDs) are synthetic ligands of Peroxisome-Proliferator-Activated Receptor gamma (PPARγ). Troglitazone, rosiglitazone, and pioglitazone have been approved for treatment of diabetes mellitus type II. All three compounds, together with the first TZD ciglitazone, also showed an antit...
שמור ב:
| הוצא לאור ב: | Biomed Res Int |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Hindawi Publishing Corporation
2015
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4383438/ https://ncbi.nlm.nih.gov/pubmed/25866814 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2015/845340 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|